Cellnovo’s Patch Pump Gains European Approval
At EASD, Cellnovo announced that it had received approval in Europe for its new insulin patch pump. It will be launched soon in the UK, and its submission to the FDA is expected by the end of the year — meaning that approval in the US could come as early as 2012. The company’s product is different from other pumps on the market. The pump is worn on the body (like Insulet’s OmniPod), uses a very short infusion set (similar to a standard insulin pump infusion set, but only about four inches long and unlike Insulet, which does not use infusion sets), and communicates wirelessly to a handheld touch-screen controller. Users will get two reusable pumps so that one can be worn while the other is recharging. The pump also has a built-in accelerometer, which allows it to loosely monitor a user’s activity levels. The pump handset automatically transmits information (blood glucose, activity, pump, food) to an online portal.